Pacira BioSciences Inc
PCRX
Market Cap$1.2B
Close$
$58.75
119.7% upside
Current Fair Value
119.7% upsideUndervalued by 119.7% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $1.20 Billion |
|---|---|
| Enterprise Value | $1.55 Billion |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-2.15 |
| Beta | 0.56 |
| Outstanding Shares | 46,275,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -11.53 |
|---|---|
| PEG | 24.84 |
| Price to Sales | 1.78 |
| Price to Book Ratio | 1.57 |
| Enterprise Value to Revenue | 2.2 |
| Enterprise Value to EBIT | -23.21 |
| Enterprise Value to Net Income | -15 |
| Total Debt to Enterprise | 0.41 |
| Debt to Equity | 0.8 |
Revenue Sources
No data
Insider Trades
ESG Score
No data